Maria T. Loste-Arias

Valdecilla, CB, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Ultrastructural analysis of transjugular biopsies in MASLD reveals core hepatocellular stress and cytoskeletal adaptations.

Ultrastructural analysis of transjugular biopsies in MASLD reveals core hepatocellular stress and cytoskeletal adaptations.

Journal: Revista espanola de enfermedades digestivas

Published: January 22, 2026

Ultrastructural analysis of transjugular biopsies in MASLD reveals core hepatocellular stress and cytoskeletal adaptations.

Ultrastructural analysis of transjugular biopsies in MASLD reveals core hepatocellular stress and cytoskeletal adaptations.

Journal: Revista espanola de enfermedades digestivas

Published: January 22, 2026

Autoantibodies are associated with worse outcomes in MASLD.

Autoantibodies are associated with worse outcomes in MASLD.

Journal: JHEP reports : innovation in hepatology

Published: January 29, 2025

Reply to: "The HDL criterion for MetALD can misclassify patients with cirrhosis".

Reply to: "The HDL criterion for MetALD can misclassify patients with cirrhosis".

Journal: Journal of hepatology

Published: January 14, 2025

Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study.

Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study.

Journal: Journal of hepatology

Published: November 14, 2024

Lights and shadows in the new definition of steatotic liver disease.

Lights and shadows in the new definition of steatotic liver disease.

Journal: Revista espanola de enfermedades digestivas

Published: September 05, 2024

Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Journal: Hepatology (Baltimore, Md.)

Published: June 13, 2024

Polygenic risk score in cirrhosis: Does the etiology matter?

Polygenic risk score in cirrhosis: Does the etiology matter?

Journal: Hepatology communications

Published: May 30, 2024

Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.

Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 26, 2024

One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.

One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.

Journal: United European gastroenterology journal

Published: February 02, 2024

Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial.

Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 29, 2023

An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease.

An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease.

Journal: Med (New York, N.Y.)

Published: December 18, 2023

Showing 1-12 of 70

Last Updated: 09/26/2026